The stock of Oxford Lane Capital faced significant selling pressure as the business development company announced a new preferred share offering. While the move aims to strengthen the firm’s balance sheet, common shareholders reacted negatively, sending the equity to a fresh annual low.
Shareholder Concerns Mount as Equity Hits New Low
Investor sentiment turned decidedly negative following the capital raise announcement. Trading on Friday saw elevated volume, with approximately 1.77 million shares changing hands. The common stock declined roughly four percent during the
Details of the $60 Million Offering
To bolster its financial position, Oxford Lane Capital disclosed terms for issuing 2.4 million shares of its 8.25% Series 2031 Term Preferred Stock. The securities were priced at $25.00 per share, aiming to generate gross proceeds of $60 million. The offering’s underwriters, Lucid Capital Markets and Piper Sandler, have been granted a 30-day option to purchase up to an additional 360,000 shares. Settlement and delivery of the shares are scheduled for March 20, after which they are expected to list on the NASDAQ.
Should investors sell immediately? Or is it worth buying Oxford Lane Capital?
Management outlined that the capital infusion will not be directed toward new portfolio investments in the immediate term. A portion of the net proceeds is designated for repaying outstanding debt, with the remainder allocated for general corporate purposes, including safeguarding liquidity.
Institutional Interest and Upcoming Dividend
Despite the prolonged weakness in the common stock price, some institutional investors have increased their stakes. Regulatory filings show that Karpus Management, for instance, added over half a million shares to its position late last year. This activity brings total institutional ownership to approximately 6.74 percent.
For current common shareholders, attention now shifts to the upcoming dividend date. The company has maintained its policy of monthly distributions despite the share price downturn. The stock will trade ex-dividend on Tuesday, March 17.
Ad
Oxford Lane Capital Stock: Buy or Sell?! New Oxford Lane Capital Analysis from March 14 delivers the answer:
The latest Oxford Lane Capital figures speak for themselves: Urgent action needed for Oxford Lane Capital investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from March 14.
Oxford Lane Capital: Buy or sell? Read more here...
